Medicis, Hyperion deal

MRX's Ucyclyd Pharma Inc. subsidiary granted Hyperion rights to research and develop GT4P to treat urea cycle disorder (UCD) and hepatic encephalopathy, and Ammonul to treat the latter indication. G...